By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



Ewert Place, Summertown

Oxford    OX2 7SG  United Kingdom
Phone: n/a Fax: n/a



Company News
Cytox Raises £2.6 Million Led By Catapult Ventures To Launch Predictive Test For Alzheimer’s Disease 6/15/2017 10:04:06 AM
Cytox Launches Breakthrough Genetic Biomarker Research Assay For Alzheimer’s Disease Risk Assessment 7/22/2016 9:08:32 AM
Cytox Announces Participation In INSIGHT Alzheimer’s Study 10/12/2015 10:49:51 AM
Cytox And Affymetrix (Santa Clara, California) (AFFX) Form Strategic Partnership To Develop And Commercialize Blood-Based Genetic Assay For Alzheimer’s Disease Risk Assessment 7/20/2015 10:22:32 AM
Cytox Signs Research Agreement With AIBL And Partner Organisations 6/1/2015 2:43:00 PM
Cytox Awarded Innovate UK Funding For Stratification Of Neurodegenerative Diseases 4/20/2015 11:04:07 AM
Cytox Release: Role Of mTOR Pathway As A Marker Of Risk In Alzheimer's Disease To Be Presented At AAIC 2014 7/14/2014 10:25:00 AM
Cytox Closes £1.5M Second Round Of Funding For Alzheimer’s Biomarker 4/3/2014 9:17:54 AM
Cytox Starts Clinical Evaluation Of Novel Mtor Blood Tests For Dementia 3/6/2014 9:48:44 AM
Cytox Blood Test Shows Statistically Significant Association With Alzheimer's Disease (AD), May Predict Conversion of Mild Cognitive Impairment to AD 7/16/2009 8:23:20 AM